Skip to main content
Erschienen in: Journal of Neurology 11/2013

01.11.2013 | Original Communication

Cerebral FDG-PET and MRI findings in autoimmune limbic encephalitis: correlation with autoantibody types

verfasst von: Annette Baumgartner, Sebastian Rauer, Irina Mader, Philipp T. Meyer

Erschienen in: Journal of Neurology | Ausgabe 11/2013

Einloggen, um Zugang zu erhalten

Abstract

In parallel to the detection of new neuronal autoantibodies, the diagnosis of non-infectious limbic encephalitis has risen. Given that cerebral imaging studies show highly variable results, the present retrospective study investigates imaging findings in association with autoantibody type. An institutional database search identified 18 patients with non-infectious limbic encephalitis who had undergone [18F] fluorodeoxyglucose positron emission tomography (FDG-PET). Sixteen of these patients also underwent magnetic resonance imaging (MRI). MRI and FDG-PET images were categorized as follows: normal (0); mesiotemporal abnormality (1); normal mesiotemporal finding but otherwise abnormal (2). Neuronal autoantibodies were determined in serum and/or CSF. Autoantibodies were grouped according to the cellular localization of their target antigen: antibodies against surface antibodies (i.e., VGKC, NMDAR): 9; antibodies against intracellular antigens (i.e., Hu, Ri, GAD): 4; no autoantibodies: 5. The fraction of abnormal scans was lower for MRI (10/16) than for FDG-PET (14/18). There was a significant association between PET findings and autoantibody type: All patients with autoantibodies against intracellular antigens showed mesiotemporal findings on FDG-PET. In turn, only 2/9 patients with autoantibodies against surface antigens displayed mesiotemporal hypermetabolism. In the remaining seven patients, four scans were rated as normal and three only showed findings outside the mesiotemporal region. A similar association was found using MRI, although this did not reach statistical significance. Autoantibody type was found to be associated with FDG-PET and, to a lesser extent, with MRI imaging results. Our observations may explain the heterogeneity of imaging data in LE and based on in vivo findings support the assumption of different patho mechanisms underlying LE due to antibodies against surface and intracellular antigens, respectively.
Literatur
1.
Zurück zum Zitat Scheid R, Lincke T, Voltz R et al (2004) Serial 18F-fluoro-2-deoxy-d-glucose positron emission tomography and magnetic resonance imaging of paraneoplastic limbic encephalitis. Arch Neurol 61:1785–1789PubMedCrossRef Scheid R, Lincke T, Voltz R et al (2004) Serial 18F-fluoro-2-deoxy-d-glucose positron emission tomography and magnetic resonance imaging of paraneoplastic limbic encephalitis. Arch Neurol 61:1785–1789PubMedCrossRef
2.
Zurück zum Zitat Provenzale JM, Barboriak DP, Coleman RE (1998) Limbic encephalitis: comparison of FDG-PET and MR imaging findings. Am J Roentgenol 170:1659–1660CrossRef Provenzale JM, Barboriak DP, Coleman RE (1998) Limbic encephalitis: comparison of FDG-PET and MR imaging findings. Am J Roentgenol 170:1659–1660CrossRef
3.
Zurück zum Zitat Hoffmann LA, Jarius S, Pellkofer HL et al (2008) Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases. J Neurol Neurosurg Psychia 79:767–773CrossRef Hoffmann LA, Jarius S, Pellkofer HL et al (2008) Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases. J Neurol Neurosurg Psychia 79:767–773CrossRef
4.
Zurück zum Zitat Greiner H, Leach JL, Lee KH et al (2011) Anti-NMDA receptor encephalitis presenting with imaging findings and clinical features mimicking Rasmussen syndrome. Seizure 20:266–270PubMedCrossRef Greiner H, Leach JL, Lee KH et al (2011) Anti-NMDA receptor encephalitis presenting with imaging findings and clinical features mimicking Rasmussen syndrome. Seizure 20:266–270PubMedCrossRef
5.
Zurück zum Zitat Pillai SC, Gill D, Webster R et al (2010) Cortical hypometabolism demonstrated by PET in relapsing NMDA receptor encephalitis. Pediatr Neurol 43:217–220PubMedCrossRef Pillai SC, Gill D, Webster R et al (2010) Cortical hypometabolism demonstrated by PET in relapsing NMDA receptor encephalitis. Pediatr Neurol 43:217–220PubMedCrossRef
6.
Zurück zum Zitat Prüss H, Dalmau J, Harms L et al (2010) Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin. Neurology 75:1735–1739PubMedCrossRef Prüss H, Dalmau J, Harms L et al (2010) Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin. Neurology 75:1735–1739PubMedCrossRef
7.
Zurück zum Zitat Ishiura H, Matsuda S, Higashihara M et al (2008) Response of anti-NMDA receptor encephalitis without tumour to immunotherapy including rituximab. Neurology 71:1921–1923PubMedCrossRef Ishiura H, Matsuda S, Higashihara M et al (2008) Response of anti-NMDA receptor encephalitis without tumour to immunotherapy including rituximab. Neurology 71:1921–1923PubMedCrossRef
8.
Zurück zum Zitat Vitaliani R, Mason W, Ances B et al (2005) Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol 58:594–604PubMedCrossRef Vitaliani R, Mason W, Ances B et al (2005) Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol 58:594–604PubMedCrossRef
9.
Zurück zum Zitat Gultekin SH, Rosenfeld MR, Voltz R et al (2000) Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 123:1481–1494PubMedCrossRef Gultekin SH, Rosenfeld MR, Voltz R et al (2000) Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 123:1481–1494PubMedCrossRef
10.
Zurück zum Zitat Dalmau J, Tüzün E, Wu HY et al (2007) Paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61:25–36PubMedCrossRef Dalmau J, Tüzün E, Wu HY et al (2007) Paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61:25–36PubMedCrossRef
11.
Zurück zum Zitat Maqbool M, Oleske DA, Huq AH et al (2011) Novel FDG-PET findings in NMDA receptor encephalitis: a case based report. Child Neurol 26:1325–1328CrossRef Maqbool M, Oleske DA, Huq AH et al (2011) Novel FDG-PET findings in NMDA receptor encephalitis: a case based report. Child Neurol 26:1325–1328CrossRef
12.
Zurück zum Zitat Caballero PE (2011) Fluorodeoxyglucose positron emission tomography findings in NMDA receptor antibody encephalitis. Arq Neuropsiquiatr 69:409–410PubMedCrossRef Caballero PE (2011) Fluorodeoxyglucose positron emission tomography findings in NMDA receptor antibody encephalitis. Arq Neuropsiquiatr 69:409–410PubMedCrossRef
13.
Zurück zum Zitat Padma S, Sundaram PS, Marmattom BV (2011) PET/CT in the evaluation of anti-NMDA-receptor encephalitis: what we need to know as a NM physician. Ind J Nucl Med 26:99–101CrossRef Padma S, Sundaram PS, Marmattom BV (2011) PET/CT in the evaluation of anti-NMDA-receptor encephalitis: what we need to know as a NM physician. Ind J Nucl Med 26:99–101CrossRef
14.
Zurück zum Zitat Haberlandt E, Bast T, Ebner A et al (2011) Limbic encephalitis in children and adolescents. Arch Dis Child 96:186–191PubMedCrossRef Haberlandt E, Bast T, Ebner A et al (2011) Limbic encephalitis in children and adolescents. Arch Dis Child 96:186–191PubMedCrossRef
15.
Zurück zum Zitat Maeder-Ingvar M, Prior JO, Irani SR et al (2011) FDG-PET hyperactivity in basal ganglia correlating with clinical course in anti-NDMA-R antibodies encephalitis. J Neurol Neurosurg Psychia 82:235–236CrossRef Maeder-Ingvar M, Prior JO, Irani SR et al (2011) FDG-PET hyperactivity in basal ganglia correlating with clinical course in anti-NDMA-R antibodies encephalitis. J Neurol Neurosurg Psychia 82:235–236CrossRef
16.
Zurück zum Zitat Guenther A, Brodoehl S, Witte OW et al (2012) Atypical posthypoxic MRI changes in hypermetabolic regions in anti-NMDA-receptor encephalitis. Neurology 79:720–721CrossRef Guenther A, Brodoehl S, Witte OW et al (2012) Atypical posthypoxic MRI changes in hypermetabolic regions in anti-NMDA-receptor encephalitis. Neurology 79:720–721CrossRef
17.
Zurück zum Zitat Irani SR, Bera K, Waters P et al (2010) N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and para clinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 133:1655–1667PubMedCrossRef Irani SR, Bera K, Waters P et al (2010) N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and para clinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 133:1655–1667PubMedCrossRef
18.
Zurück zum Zitat Chatzikonstantinou A, Szabo K, Ottomeyer C et al (2009) Successive affection of bilateral temporomesial structures in a case of non-paraneoplastic limbic encephalitis demonstrated by serial MRI and FDG-PET. J Neurol 256:1753–1755PubMedCrossRef Chatzikonstantinou A, Szabo K, Ottomeyer C et al (2009) Successive affection of bilateral temporomesial structures in a case of non-paraneoplastic limbic encephalitis demonstrated by serial MRI and FDG-PET. J Neurol 256:1753–1755PubMedCrossRef
19.
Zurück zum Zitat Troester F, Weske G, Schlaudraff E et al (2009) Image of the month. FDG-PET in paraneoplastic limbic encephalitis. Eur J Nucl Med Mol Imag 36:539CrossRef Troester F, Weske G, Schlaudraff E et al (2009) Image of the month. FDG-PET in paraneoplastic limbic encephalitis. Eur J Nucl Med Mol Imag 36:539CrossRef
20.
Zurück zum Zitat Ances BM, Vitaliani R, Taylor RA et al (2005) Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain 128:1764–1777PubMedCrossRef Ances BM, Vitaliani R, Taylor RA et al (2005) Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain 128:1764–1777PubMedCrossRef
21.
Zurück zum Zitat Kassubek J, Juengling FD, Nitzsche EU et al (2001) Limbic encephalitis investigated by 18 FDG-PET and 3D MRI. J Neuroimag 11:55–59CrossRef Kassubek J, Juengling FD, Nitzsche EU et al (2001) Limbic encephalitis investigated by 18 FDG-PET and 3D MRI. J Neuroimag 11:55–59CrossRef
22.
Zurück zum Zitat Mohr BC, Minoshima S (2010) F-18 fluorodeoxyglucose PET/CT findings in a case of anti-NMDA receptor encephalitis. Clin Nucl Med 35:461–463PubMedCrossRef Mohr BC, Minoshima S (2010) F-18 fluorodeoxyglucose PET/CT findings in a case of anti-NMDA receptor encephalitis. Clin Nucl Med 35:461–463PubMedCrossRef
23.
Zurück zum Zitat Leypoldt F, Buchert R, Kleiter I et al (2012) Fluorodeoxyglucose positron emission tomography in anti-N-methyl-d-aspartate receptor encephalitis: distinct pattern of disease. J Neurol Neurosurg Psychia 83:681–686CrossRef Leypoldt F, Buchert R, Kleiter I et al (2012) Fluorodeoxyglucose positron emission tomography in anti-N-methyl-d-aspartate receptor encephalitis: distinct pattern of disease. J Neurol Neurosurg Psychia 83:681–686CrossRef
24.
Zurück zum Zitat Rey C, Koric L, Guedj E et al (2012) Striatal hypermetabolism in limbic encephalitis. J Neurol 259:1106–1110PubMedCrossRef Rey C, Koric L, Guedj E et al (2012) Striatal hypermetabolism in limbic encephalitis. J Neurol 259:1106–1110PubMedCrossRef
25.
Zurück zum Zitat Malter MP, Helmstaedter C, Urbach H et al (2010) Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann Neurol 67:470–478PubMedCrossRef Malter MP, Helmstaedter C, Urbach H et al (2010) Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann Neurol 67:470–478PubMedCrossRef
26.
Zurück zum Zitat Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W et al (2004) Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychia 75:1135–1140CrossRef Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W et al (2004) Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychia 75:1135–1140CrossRef
27.
Zurück zum Zitat Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M et al (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lan Neurol 7:1091–1098CrossRef Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M et al (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lan Neurol 7:1091–1098CrossRef
28.
Zurück zum Zitat Vincent A, Bien CG, Irani SR, Waters P (2011) Autoantibodies associated with diseases of the CNS: new developments and future challenges. Lan Neurol 10:759–772CrossRef Vincent A, Bien CG, Irani SR, Waters P (2011) Autoantibodies associated with diseases of the CNS: new developments and future challenges. Lan Neurol 10:759–772CrossRef
29.
Zurück zum Zitat Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE (1995) A diagnostic approach in Alzheimer’s disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 36:1238–1248PubMed Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE (1995) A diagnostic approach in Alzheimer’s disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 36:1238–1248PubMed
30.
Zurück zum Zitat Hellwig S, Amtage F, Kreft A, Buchert R, Winz OH, Vach W et al (2012) [18F]FDG-PET is superior to [123I]IBZM-SPECT for the differential diagnosis of parkinsonism. Neurology 79:1314–1322PubMedCrossRef Hellwig S, Amtage F, Kreft A, Buchert R, Winz OH, Vach W et al (2012) [18F]FDG-PET is superior to [123I]IBZM-SPECT for the differential diagnosis of parkinsonism. Neurology 79:1314–1322PubMedCrossRef
31.
Zurück zum Zitat Blanc F, Ruppert E, Kleitz C, Valenti MP, Cretin B, Humbel RL et al (2009) Acute limbic encephalitis and glutamic acid decarboxylase antibodies: a reality? J Neurol Sci 287:69–71PubMedCrossRef Blanc F, Ruppert E, Kleitz C, Valenti MP, Cretin B, Humbel RL et al (2009) Acute limbic encephalitis and glutamic acid decarboxylase antibodies: a reality? J Neurol Sci 287:69–71PubMedCrossRef
32.
Zurück zum Zitat Fisher RE, Patel NR, Lai EC, Schulz PE (2012) Two different 18F-FDG brain PET metabolic patterns in autoimmune limbic encephalitis. Clin Nucl Med 37:213–218CrossRef Fisher RE, Patel NR, Lai EC, Schulz PE (2012) Two different 18F-FDG brain PET metabolic patterns in autoimmune limbic encephalitis. Clin Nucl Med 37:213–218CrossRef
33.
Zurück zum Zitat Bien CG, Vincent A, Barnett MH, Becker AJ, Blümcke I, Graus F et al (2012) Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. Brain 135:1622–1638PubMedCrossRef Bien CG, Vincent A, Barnett MH, Becker AJ, Blümcke I, Graus F et al (2012) Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. Brain 135:1622–1638PubMedCrossRef
34.
Zurück zum Zitat Hughes EG, Peng X, Gleichman AJ, Lai M, Zhou L, Tsou R et al (2010) Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci 30:5866–5875PubMedCrossRef Hughes EG, Peng X, Gleichman AJ, Lai M, Zhou L, Tsou R et al (2010) Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci 30:5866–5875PubMedCrossRef
35.
Zurück zum Zitat Pellkofer HL, Kuempfel T, Jacobson L, Vincent A, Derfuss T (2010) Non-paraneoplastic limbic encephalitis associated with NMDAR and VGKC antibodies. J Neurol Neurosurg Psychia 81:1407–1408CrossRef Pellkofer HL, Kuempfel T, Jacobson L, Vincent A, Derfuss T (2010) Non-paraneoplastic limbic encephalitis associated with NMDAR and VGKC antibodies. J Neurol Neurosurg Psychia 81:1407–1408CrossRef
Metadaten
Titel
Cerebral FDG-PET and MRI findings in autoimmune limbic encephalitis: correlation with autoantibody types
verfasst von
Annette Baumgartner
Sebastian Rauer
Irina Mader
Philipp T. Meyer
Publikationsdatum
01.11.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 11/2013
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-013-7048-2

Weitere Artikel der Ausgabe 11/2013

Journal of Neurology 11/2013 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.